T2 Biosystems Inc (TTOO)
0.4302
0.00 (0.00%)
USD |
NASDAQ |
Nov 22, 10:14
T2 Biosystems Enterprise Value: 18.80M for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 18.80M |
| November 20, 2024 | 19.56M |
| November 19, 2024 | 20.00M |
| November 18, 2024 | 20.57M |
| November 15, 2024 | 20.30M |
| November 14, 2024 | 20.78M |
| November 13, 2024 | 21.37M |
| November 12, 2024 | 20.87M |
| November 11, 2024 | 22.34M |
| November 08, 2024 | 20.72M |
| November 07, 2024 | 23.19M |
| November 06, 2024 | 22.60M |
| November 05, 2024 | 24.79M |
| November 04, 2024 | 24.85M |
| November 01, 2024 | 25.80M |
| October 31, 2024 | 26.27M |
| October 30, 2024 | 27.66M |
| October 29, 2024 | 28.00M |
| October 28, 2024 | 29.54M |
| October 25, 2024 | 30.10M |
| October 24, 2024 | 33.48M |
| October 23, 2024 | 36.85M |
| October 22, 2024 | 38.73M |
| October 21, 2024 | 36.67M |
| October 18, 2024 | 36.10M |
| Date | Value |
|---|---|
| October 17, 2024 | 35.35M |
| October 16, 2024 | 36.10M |
| October 15, 2024 | 36.85M |
| October 14, 2024 | 37.42M |
| October 11, 2024 | 37.60M |
| October 10, 2024 | 37.98M |
| October 09, 2024 | 40.23M |
| October 08, 2024 | 39.29M |
| October 07, 2024 | 40.42M |
| October 04, 2024 | 43.98M |
| October 03, 2024 | 43.98M |
| October 02, 2024 | 45.11M |
| October 01, 2024 | 44.73M |
| September 30, 2024 | 46.80M |
| September 27, 2024 | 42.50M |
| September 26, 2024 | 42.15M |
| September 25, 2024 | 42.68M |
| September 24, 2024 | 43.38M |
| September 23, 2024 | 43.55M |
| September 20, 2024 | 45.82M |
| September 19, 2024 | 46.00M |
| September 18, 2024 | 45.12M |
| September 17, 2024 | 46.87M |
| September 16, 2024 | 47.92M |
| September 13, 2024 | 51.77M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
18.80M
Minimum
Nov 21 2024
28.06B
Maximum
Feb 08 2021
3.807B
Average
2.015B
Median
Feb 10 2020
Enterprise Value Benchmarks
| Boston Scientific Corp | 143.48B |
| Cardinal Health Inc | 32.17B |
| Perspective Therapeutics Inc | -63.40M |
| Electromed Inc | 223.55M |
| Xtant Medical Holdings Inc | 85.83M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -10.12M |
| Revenue (Quarterly) | 1.985M |
| Total Expenses (Quarterly) | 12.15M |
| EPS Diluted (Quarterly) | -0.57 |
| Gross Profit Margin (Quarterly) | -106.6% |
| Profit Margin (Quarterly) | -509.7% |
| Earnings Yield | -1.49K% |
| Normalized Earnings Yield | -1512.57 |